We are active in pharmaceutical associations (e.g. AIPM and Healthcare Committee of AmCham). One of recent public projects of our team is development of consolidated position and acting in the interest of pharmaceutical companies at the expect council of the Federal Antimonopoly Service to adjust the regulator’s practice on the advertisement of medications, that was successful and well-received by the professional society.
We are convinced that our unique resources and the hands-on experience accumulated by our integrated team over many years of practising law on the market are the bedrock that guarantees superior service to our clients.